Skip to main content

Select Drug Profiles

Original Research
Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
Kelvin Lingjet Tran, DO, Young In Park, DO, Shalin Pandya, DO, Navin John Muliyil, DO, Brandon David Jensen, DO, Kovin Huynh, DO, Quang T. Nguyen, DO, FACE, FTOS
Kelvin Lingjet Tran, DO; Young In Park, DO; Shalin Pandya, DO; Navin John Muliyil, DO; Brandon David Jensen, DO; Kovin Huynh, DO; Quang T. Nguyen, DO, FACP, FACE, FTOS
Stakeholder Perspective
The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
Raymond Plodkowski, MD
by Raymond A. Plodkowski, MD
Read More
Conference Highlights AMCP
Challenges and Opportunities in Managing Type 2 Diabetes
Laura Morgan
Laura Morgan
Read More
Original Research, Practice Management
The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers
Kathryn Fitch, RN, MEd, J. Michael Woolley, PhD, Tyler Engel, ASA, MAAA, Helen Blumen, MD, MBA
Kathryn Fitch, RN, MEd; J. Michael Woolley, PhD; Tyler Engel, ASA, MAAA; Helen Blumen, MD, MBA
Stakeholder Perspective
Hyperkalemia in Chronic Diseases: A Serious Medical Condition in Need of Clinical Guidelines and New Treatment Options
Quang T. Nguyen, DO, FACP, FACE, FTOS
by Quang T. Nguyen, DO, FACE, FTOS
Read More
Perspectives
“Sunshine Is the Best Disinfectant”
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Original Research
Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas
Kelly F. Bell, PharmD, MSPhr, MS, Katherine Cappell, PhD, Michael Liang, MS, Amanda M. Kong, MPH
Kelly F. Bell, PharmD, MSPhr, MS; Katherine Cappell, PhD; Michael Liang, MS; Amanda M. Kong, MPH
Stakeholder Perspective
Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence
Brian Caveney, MD, JD, MPH
by Brian Caveney, MD, JD, MPH
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
Phase 1 Dose Escalation of Ibrutinib and Buparlisib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Mantle-Cell Lymphoma, and Follicular Lymphoma
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
KI Intolerance Study: A Phase 2 Study to Assess the Safety and Efficacy of TGR-1202 in Patients with CLL Intolerant to Prior Bruton’s Tyrosine Kinase or PI3Kδ Inhibitor Therapy
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
iFCG for Previously Untreated Patients with CLL with Mutated IGHV and Non-Del(17p)
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
Results of a Phase 2 Multicenter Study of Obinutuzumab plus Bendamustine in Patients with Previously Untreated CLL
Read More
ASCO 2017 - Chronic Lymphocytic Leukemia
CD19 CAR T-Cells Combined with Ibrutinib to Induce Complete Remission in CLL
Read More
Page 87 of 244
Results 861 - 870 of 2434